Navigation Links
NewCardio Leadership to Make Two Presentations at Drug Information Association Drug Safety Conference
Date:4/7/2009

Company to Present and Participate in Panel Discussions at DIA Conference in Bethesda, Maryland April 29-May 1, 2009

SANTA CLARA, Calif., April 7 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced that senior leadership will present clinical data, discuss applications for its proprietary technology, and participate in panel discussion at the Drug Information Association (DIA) Cardiovascular Safety and QT/Arrhythmia Assessment in Drug Development - Optimizing Drug Development Conference. The conference, co-sponsored by the FDA and the Heart Rhythm Society, is scheduled from April 29 through May 1, 2009 in Bethesda, Maryland.

Dr. Ihor Gussak, NewCardio's Vice President and Chief Medical Officer, will discuss Automatic ECG Analysis, based on the Company's proprietary three-dimensional platform and its QTinno(TM) solution. This is a special session on Automatic QT Assessment and multiple investigators are being asked to provide a structured discussion, covering technical approaches, including how analysis is performed, for emerging technologies, validation data, the amount of over-reading necessary, morphology analysis and an evaluation of risk factors. Dr. Gussak will participate in conference panel discussions as well.

In addition, the Company has been invited to make a second presentation, "Differential Effects of D-Sotalol and a Flouroquinolone Antibiotic on T-wave Morphology and Ventricular Repolarization." Dr. Gussak will also make this presentation and participate in a subsequent discussion.

The DIA conference will feature regulatory, industry, and scientific leaders from around the world who will discuss the evolution of drug development, cardiac repolarization, and cardiovascular (CV) safety. This open forum will discuss the new direction in the development of pharmaceut
'/>"/>

SOURCE NewCardio, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. NewCardio Elects Michael E. Hanson to Board of Directors
2. UPDATE: NewCardio Leadership to Present Clinical Data of Fully Automated QTinno(TM) Study at American College of Cardiology Annual Meeting
3. NewCardio Leadership to Present Clinical Data of Fully Automated QTinno(TM) Study at American College of Cardiology Annual Meeting
4. NewCardio to Present at OneMedForum 2009: Disrupters and Drivers on January 13 in San Francisco
5. NewCardio Restructures 2007 Financing, Receives $2.8 Million Additional Cash and Improves Capital Structure
6. NewCardio Announces New Client Services Team
7. Pfizer Animal Health Becomes Leadership Contributor to the NTRA Safety and Integrity Alliance
8. iMedica Announces New Leadership for Regional Sales Teams
9. New Coaching Program Helps Charge Nurses Develop Leadership Skills: B. E. Smith's Coaches Develop High Performers Who Improve Hospital Finances
10. Bentley University Presents Fifth Annual Bentley Leadership Forum, in Cooperation With TIME
11. Girl Scouts of Eastern Pennsylvanias Young Womens Leadership Conference Offers a Day of Workshops on Creating A Healthier You
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... A new program for the "In America" television series ... Therapy. , James Earl Jones will host the ... therapy and discusses how the exercises can decrease pain ... ailments and injuries. Physical therapists work with their ... daily activities such as house cleaning and shopping, work ...
(Date:5/22/2015)... 2015 Javon Bea Mercy Health ... for providing the highest quality emergency care services, especially ... decision-making,” said Javon R. Bea, President and CEO of ... our employee/partners to care for and respond to what ... not apply for this award, but are selected if ...
(Date:5/21/2015)... 2015 WellCare Health Plans, Inc. (NYSE: WCG) ... by the Florida Healthy Kids Corporation (FHKC) to continue to ... as part of the Florida Healthy Kids (FHK) program. Pending ... and may be extended for two additional years at FHKC’s ... in the FHK program who live in Regions 1, 2, ...
(Date:5/21/2015)... How do you stop head lice epidemics in schools? This ... but a Miami Lice Removal Company, Lice Troopers, the ... devising new ways to stop the spread. , As ... step is education and prevention. Despite the ubiquity of head ... spread are still widely misunderstood. Many continue to equate the ...
(Date:5/21/2015)... (PRWEB) May 21, 2015 Many probiotics ... effect on those with celiac disease according to a ... half of the probiotics tested in the study contained ... and dietary supplements and cause gastrointestinal inflammation for those ... aiming to gain consumer trust in gluten-free claims have ...
Breaking Medicine News(10 mins):Health News:Mercy Hospital and Trauma Center Receives Women’s Choice Award for Emergency Care - Mercy Health System Javon Bea 2Health News:WellCare Selected to Continue Participating in the Florida Healthy Kids Program, Will Serve Nine Florida Regions Under the New Contract 2Health News:Local Lice Removal Company Partners with Schools to Combat Head Lice in the Classroom as Increase in Number of Cases Reported in May. 2Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 2Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 3Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 4
... deaths in the United States are linked to behavioral and ... these causal links, of the $2 trillion spent annually on ... is devoted to addressing behavioral and social risk factors. ... and social sciences with a new $500,000 grant from the ...
... between the social impairments found in autism and schizophrenia ... disorders. Autism spectrum disorder (ASD) and schizophrenia are ... in social dysfunction. For many years, this similarity resulted ... were thought to have a childhood version of schizophrenia, ...
... with pancreatic cancer may be one step closer to ... in some cases but not in others, according to ... of the American Association for Cancer Research. ... medicine at the University of Cambridge, utilized a laboratory ...
... , TUESDAY, Feb. 28 (HealthDay News) --,Vegetarians ... cultural reasons may unknowingly be consuming gelatin derived ... new study found. Animal-derived gelatin is a commonly ... used as a thickener in some liquid and semisolid ...
... 2012) A great deal has been learned in the ... Health Initiative (WHI). Hormone therapy (HT) remains the most effective ... there is a growing body of evidence that formulation, route ... produce different effects. It is essential to evaluate ...
... study headed up by the Vall d,Hebron Institute of Oncology ... opening up a parallel dimension to existing treatment options. The ... , demonstrate that by combining two drugs that had already ... stopped working, they boost each other,s efficacy and at the ...
Cached Medicine News:Health News:Training grant targets behavioral and social factors linked to health 2Health News:Training grant targets behavioral and social factors linked to health 3Health News:Study compares traits of autism, schizophrenia 2Health News:Many Vegetarians Unaware of Animal-Derived Gels in Pills 2Health News:The North American Menopause Society (NAMS) reassures many women 2Health News:A giant little step in cancer treatment opening up new therapeutic horizons 2
(Date:5/22/2015)... 2015 Richmond Pharmacology is ... with a worldwide reputation for excellence in clinical ... in peer reviewed medical journals. Its officers are ... in discussions about rules for transparency and publication ... http://photos.prnewswire.com/prnh/20150522/745125) , Clinical research is conducted ...
(Date:5/21/2015)...  When Ryan Rendino first felt the ... neck, he figured it was a muscle ... from weight lifting. But the ... A series of doctor appointments followed ... Michel Kliot, MD , a Northwestern ...
(Date:5/21/2015)... , May 21, 2015  CryoLife, Inc. (NYSE: ... processing company focused on cardiac and vascular surgery, announced ... quarterly cash dividend for the second quarter 2015 of ... cash dividend of $0.03 per share will be paid ... record as of June 12, 2015.  The ex-dividend date ...
Breaking Medicine Technology:Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4CryoLife Announces Quarterly Cash Dividend for the Second Quarter 2015 2
... 2011 K-V Pharmaceutical Company (the "Company") (NYSE: ... of Obstetricians and Gynecologists (ACOG) and Society for ... and ensure that healthcare providers, patients, and the ...  The information update from ACOG and SMFM confirms ...
... MONTREAL, Oct. 13, 2011 A Medco Health Solutions, ... found that 38 percent of patients prescribed Plavix® (clopidogrel)—an ... and stroke—were also using another drug that would impede ... The analysis also showed that primary care physicians ...
Cached Medicine Technology:K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 2K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 3K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 4K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 5K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 6K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 7K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 8Putting Gene Tests to Use: More Than a Third of Patients Cannot Properly Metabolize Plavix® 2Putting Gene Tests to Use: More Than a Third of Patients Cannot Properly Metabolize Plavix® 3Putting Gene Tests to Use: More Than a Third of Patients Cannot Properly Metabolize Plavix® 4
Solid 16 mm blades. Self-locking mechanism. Dull finish....
Speculum with malleable plate to support flap during ablation of thestromal bed....
Adjustable wire speculum with 17 mm open blades. Lid tension adjustable throughout procedure with thumb screw control. Angled 45 degrees....
Open 13 mm blades. Screw-controlled locking mechanism. Dull finish....
Medicine Products: